Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
0.6134
-0.0219 (-3.45%)
At close: Jul 16, 2026, 4:00 PM EDT
0.6260
+0.0126 (2.05%)
After-hours: Jul 16, 2026, 5:08 PM EDT
Longeveron Market Cap
Longeveron has a market cap or net worth of $19.38 million as of July 16, 2026. Its market cap has decreased by -9.06% in one year.
Market Cap
19.38M
Enterprise Value
4.67M
1-Year Change
-9.06%
Ranking
Category
Stock Price
$0.61
ChartMarket Cap Chart
Since the IPO on February 12, 2021, Longeveron's market cap has decreased from $172.48M to $19.38M, a decrease of -88.76%. That is a compound annual growth rate of -33.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 19.66M | 82.16% |
| Dec 31, 2025 | 10.79M | -57.95% |
| Dec 31, 2024 | 25.67M | -24.83% |
| Dec 29, 2023 | 34.15M | -49.55% |
| Dec 30, 2022 | 67.68M | -72.36% |
| Dec 31, 2021 | 244.90M | 41.99% |
| Feb 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Skye Bioscience | 21.79M |
| Cellectar Biosciences | 21.57M |
| NewcelX | 21.10M |
| CEL-SCI | 20.25M |
| Atossa Therapeutics | 19.90M |
| KALA BIO | 19.71M |
| SeaStar Medical Holding | 19.62M |
| Neuphoria Therapeutics | 19.38M |